FDA NDC Directory · JSON-LD · Markdown

Vasopressin in 0.9% Sodium Chloride

NDC 0338-9647 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBaxter Healthcare Corporation
Marketing categoryNew Drug Application (innovator) · App NDA217569
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsVASOPRESSIN (40 [USP'U]/100mL)
Marketing started20230929
Package count1

External sources

Source: openFDA. Public-domain (CC0).